Benmoxin

DB09246

small molecule withdrawn

Deskripsi

Benmoxin is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class. It was first synthesized in 1967 and rapidly used in Europe as an antidepressant. However, this agent is no longer marketed.

Struktur Molekul 2D

Berat 240.306
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

1322 Data
Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Benmoxin.
Dronabinol Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Benmoxin.
Droperidol Droperidol may increase the central nervous system depressant (CNS depressant) activities of Benmoxin.
Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Benmoxin.
Magnesium sulfate The therapeutic efficacy of Benmoxin can be increased when used in combination with Magnesium sulfate.
Methotrimeprazine Benmoxin may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Metyrosine Benmoxin may increase the sedative activities of Metyrosine.
Minocycline Minocycline may increase the central nervous system depressant (CNS depressant) activities of Benmoxin.
Nabilone Nabilone may increase the central nervous system depressant (CNS depressant) activities of Benmoxin.
Orphenadrine Benmoxin may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Paraldehyde Benmoxin may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Benmoxin.
Pramipexole Benmoxin may increase the sedative activities of Pramipexole.
Ropinirole Benmoxin may increase the sedative activities of Ropinirole.
Rotigotine Benmoxin may increase the sedative activities of Rotigotine.
Rufinamide The risk or severity of adverse effects can be increased when Rufinamide is combined with Benmoxin.
Sodium oxybate Benmoxin may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.
Suvorexant Benmoxin may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Thalidomide Benmoxin may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Zolpidem Benmoxin may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.
Desmopressin The risk or severity of hypertension can be increased when Desmopressin is combined with Benmoxin.
Cyclosporine The risk or severity of hypertension can be increased when Cyclosporine is combined with Benmoxin.
Icosapent The risk or severity of hypertension can be increased when Icosapent is combined with Benmoxin.
Mesalazine The risk or severity of hypertension can be increased when Mesalazine is combined with Benmoxin.
Indomethacin The risk or severity of hypertension can be increased when Indomethacin is combined with Benmoxin.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Benmoxin.
Nabumetone The risk or severity of hypertension can be increased when Nabumetone is combined with Benmoxin.
Ketorolac The risk or severity of hypertension can be increased when Ketorolac is combined with Benmoxin.
Tenoxicam The risk or severity of hypertension can be increased when Tenoxicam is combined with Benmoxin.
Celecoxib The risk or severity of hypertension can be increased when Celecoxib is combined with Benmoxin.
Tolmetin The risk or severity of hypertension can be increased when Tolmetin is combined with Benmoxin.
Rofecoxib The risk or severity of hypertension can be increased when Rofecoxib is combined with Benmoxin.
Piroxicam The risk or severity of hypertension can be increased when Piroxicam is combined with Benmoxin.
Fenoprofen The risk or severity of hypertension can be increased when Fenoprofen is combined with Benmoxin.
Valdecoxib The risk or severity of hypertension can be increased when Valdecoxib is combined with Benmoxin.
Diclofenac The risk or severity of hypertension can be increased when Diclofenac is combined with Benmoxin.
Sulindac The risk or severity of hypertension can be increased when Sulindac is combined with Benmoxin.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Benmoxin.
Flurbiprofen The risk or severity of hypertension can be increased when Flurbiprofen is combined with Benmoxin.
Etodolac The risk or severity of hypertension can be increased when Etodolac is combined with Benmoxin.
Mefenamic acid The risk or severity of hypertension can be increased when Mefenamic acid is combined with Benmoxin.
Naproxen The risk or severity of hypertension can be increased when Naproxen is combined with Benmoxin.
Sulfasalazine The risk or severity of hypertension can be increased when Sulfasalazine is combined with Benmoxin.
Phenylbutazone The risk or severity of hypertension can be increased when Phenylbutazone is combined with Benmoxin.
Meloxicam The risk or severity of hypertension can be increased when Meloxicam is combined with Benmoxin.
Carprofen The risk or severity of hypertension can be increased when Carprofen is combined with Benmoxin.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Benmoxin.
Diflunisal The risk or severity of hypertension can be increased when Diflunisal is combined with Benmoxin.
Salicylic acid The risk or severity of hypertension can be increased when Salicylic acid is combined with Benmoxin.
Meclofenamic acid The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Benmoxin.
Dopamine The risk or severity of hypertension can be increased when Dopamine is combined with Benmoxin.
Oxaprozin The risk or severity of hypertension can be increased when Oxaprozin is combined with Benmoxin.
Ketoprofen The risk or severity of hypertension can be increased when Ketoprofen is combined with Benmoxin.
Balsalazide The risk or severity of hypertension can be increased when Balsalazide is combined with Benmoxin.
Ibuprofen The risk or severity of hypertension can be increased when Ibuprofen is combined with Benmoxin.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Benmoxin.
Propafenone The risk or severity of hypertension can be increased when Propafenone is combined with Benmoxin.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Benmoxin.
Lumiracoxib The risk or severity of hypertension can be increased when Lumiracoxib is combined with Benmoxin.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Benmoxin.
Magnesium salicylate The risk or severity of hypertension can be increased when Magnesium salicylate is combined with Benmoxin.
Salsalate The risk or severity of hypertension can be increased when Salsalate is combined with Benmoxin.
Choline magnesium trisalicylate The risk or severity of hypertension can be increased when Choline magnesium trisalicylate is combined with Benmoxin.
Antrafenine The risk or severity of hypertension can be increased when Antrafenine is combined with Benmoxin.
Aminophenazone The risk or severity of hypertension can be increased when Aminophenazone is combined with Benmoxin.
Antipyrine The risk or severity of hypertension can be increased when Antipyrine is combined with Benmoxin.
Tiaprofenic acid The risk or severity of hypertension can be increased when Tiaprofenic acid is combined with Benmoxin.
Etoricoxib The risk or severity of hypertension can be increased when Etoricoxib is combined with Benmoxin.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Benmoxin.
Taxifolin The risk or severity of hypertension can be increased when Taxifolin is combined with Benmoxin.
Oxyphenbutazone The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Benmoxin.
1-benzylimidazole The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Benmoxin.
Benoxaprofen The risk or severity of hypertension can be increased when Benoxaprofen is combined with Benmoxin.
Metamizole The risk or severity of hypertension can be increased when Metamizole is combined with Benmoxin.
Zomepirac The risk or severity of hypertension can be increased when Zomepirac is combined with Benmoxin.
Dronedarone The risk or severity of hypertension can be increased when Dronedarone is combined with Benmoxin.
Cimicoxib The risk or severity of hypertension can be increased when Cimicoxib is combined with Benmoxin.
Amibegron The risk or severity of hypertension can be increased when Amibegron is combined with Benmoxin.
Nylidrin The risk or severity of hypertension can be increased when Nylidrin is combined with Benmoxin.
Solabegron The risk or severity of hypertension can be increased when Solabegron is combined with Benmoxin.
Lornoxicam The risk or severity of hypertension can be increased when Lornoxicam is combined with Benmoxin.
Aceclofenac The risk or severity of hypertension can be increased when Aceclofenac is combined with Benmoxin.
Zaltoprofen The risk or severity of hypertension can be increased when Zaltoprofen is combined with Benmoxin.
Saralasin The risk or severity of hypertension can be increased when Saralasin is combined with Benmoxin.
Azapropazone The risk or severity of hypertension can be increased when Azapropazone is combined with Benmoxin.
Parecoxib The risk or severity of hypertension can be increased when Parecoxib is combined with Benmoxin.
Salicylamide The risk or severity of hypertension can be increased when Salicylamide is combined with Benmoxin.
Tyramine The risk or severity of hypertension can be increased when Tyramine is combined with Benmoxin.
Mirabegron The risk or severity of hypertension can be increased when Mirabegron is combined with Benmoxin.
Adrafinil The risk or severity of hypertension can be increased when Adrafinil is combined with Benmoxin.
Kebuzone The risk or severity of hypertension can be increased when Kebuzone is combined with Benmoxin.
Isoxicam The risk or severity of hypertension can be increased when Isoxicam is combined with Benmoxin.
Indoprofen The risk or severity of hypertension can be increased when Indoprofen is combined with Benmoxin.
Ibuproxam The risk or severity of hypertension can be increased when Ibuproxam is combined with Benmoxin.
Floctafenine The risk or severity of hypertension can be increased when Floctafenine is combined with Benmoxin.
Fenbufen The risk or severity of hypertension can be increased when Fenbufen is combined with Benmoxin.
Etofenamate The risk or severity of hypertension can be increased when Etofenamate is combined with Benmoxin.
Etilefrine The risk or severity of hypertension can be increased when Etilefrine is combined with Benmoxin.
Epirizole The risk or severity of hypertension can be increased when Epirizole is combined with Benmoxin.
Benzydamine The risk or severity of hypertension can be increased when Benzydamine is combined with Benmoxin.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 0 • International brands: 2
International Brands
  • Nerusil
  • Neuralex

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul